[Lymphogranulomatosis in infancy. histology, therapy and prognosis (author's transl)]

Between 10 and 14% of Lymphogranulomatosis are infants. In recent years distinct advances have been made through accurate histological classification, subdivision into clinical stages and aggressive radiotherapy and polychemotherapy. Therapeutic success depends particularly on the primary extent of the disease. But some therapeutic decisions require conclusive confirmation by still lacking longterm observations. In particular the number of possible late relapses cannot be estimated at present.